Patents by Inventor Jerry Rosenbaum

Jerry Rosenbaum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6121249
    Abstract: Disclosed is the method of reducing the incidence and severity of atherosclerosis, atherosclerotic central nervous system disease, claudication, coronary artery disease, homocystine related disorders, hypertension, peripheral vascular disease, presenile dementia and/or restenosis in humans by daily administration of an effective amount of a combination of acetylsalicylic acid (ASA), at least one antioxidant, a cyanocobalamin compound (Vitamin B12), a folic acid compound, a pyridoxine compound (Vitamin B6) and a niacin compound.
    Type: Grant
    Filed: July 1, 1998
    Date of Patent: September 19, 2000
    Assignee: Donald L. Weissman
    Inventors: Donald L. Weissman, Jerry Rosenbaum
  • Patent number: 5869090
    Abstract: Disclosed is a novel transdermal delivery system for dehydroepiandrosterone (DHEA). Using phospholipids as vehicles, DHEA can be administered into and through the skin when topically applied. Numerous advantages apply to this modality of therapy.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: February 9, 1999
    Inventor: Jerry Rosenbaum
  • Patent number: 5709878
    Abstract: Disclosed is a novel transdermal delivery system for dehydroepiandrosterone (DHEA). Using phospholipids as vehicles, DHEA can be administered into and through the skin when topically applied. Numerous advantages apply to this modality of therapy.
    Type: Grant
    Filed: August 2, 1996
    Date of Patent: January 20, 1998
    Inventors: Jerry Rosenbaum, George Suarez